![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Joseph V Pergolizzi Jr & Robert B Raffa. (2019) Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain. Journal of Pain Research 12, pages 3299-3317.
Read now
Read now
Martin Hale, Veronica Urdaneta, M Todd Kirby, Qinfang Xiang & Richard Rauck. (2017) Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids. Journal of Pain Research 10, pages 233-240.
Read now
Read now
Richard L. Rauck, Jeffrey Potts, Qinfang Xiang, Evan Tzanis & Andrew Finn. (2016) Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgraduate Medicine 128:1, pages 1-11.
Read now
Read now
Ish K Khanna & Sivaram Pillarisetti. (2015) Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain. Journal of Pain Research 8, pages 859-870.
Read now
Read now
Tracy L Skaer. (2014) Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain. Journal of Pain Research 7, pages 495-503.
Read now
Read now
Articles from other publishers (50)
Marcin Chwistek, Dylan Sherry, Leigh Kinczewski, Maria J. Silveira & Mellar Davis. (2023) Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?. Journal of Pain and Symptom Management 66:5, pages e638-e643.
Crossref
Crossref
Theofilos Tsoleridis. (2023) The Use of Transdermal Buprenorphine for Acute Postherpetic Neuralgia: A Case Report. Cureus.
Crossref
Crossref
Dinesh JalukaDr.Dr. & Parthasarathi DattaDr.Dr.. (2023) COMPARISON BETWEEN SAFETY AND EFFICACY OF TRANSDERMAL BUPRENORPHINE AND FENTANYL PATCHES FOR THE MANAGEMENT OF POST-OPERATIVE PAIN FOLLOWING LUMBAR SPINAL INSTRUMENTATION.. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 58-60.
Crossref
Crossref
Zoila Trujillo De Los Santos, Jesús Aarón García Sandoval, Francisco Paz Rodríguez, María Alejandra Sánchez Guzmán & Ma. Guadalupe Nava Galán. (2023) Buprenorfina transdérmica, una alternativa en el tratamiento del dolor en pacientes con enfermedad de Parkinson Avanzada: Enfoque Paliativo.. Multidisciplinary Pain Journal, pages 1-6.
Crossref
Crossref
Jerson González-Hernández, Guillermo Moya-Alvarado, Ana Lorena Alvarado-Gámez, Roberto Urcuyo, Miriam Barquero-Quirós & María Julia Arcos-Martínez. (2022) Electrochemical biosensor for quantitative determination of fentanyl based on immobilized cytochrome c on multi-walled carbon nanotubes modified screen-printed carbon electrodes. Microchimica Acta 189:12.
Crossref
Crossref
Elie SaderMDMD, Steven CalvinoMDMD & Christopher GhariboMDMD. 2022. Complications of Pain‐Relieving Procedures. Complications of Pain‐Relieving Procedures
32
37
.
Tim Quach, Luojuan Hu, Sifei Han, Shea F. Lim, Danielle Senyschyn, Preeti Yadav, Natalie L. Trevaskis, Jamie S. Simpson & Christopher J. H. Porter. (2022) Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport. Frontiers in Pharmacology 13.
Crossref
Crossref
Isabelle Dutriez-Casteloot, Virginie Emmanuelli, Jean-François Wiart, Annabelle Tavernier, Capucine Besengez, Laurent Storme & Véronique Houfflin-Debarge. (2022) Long-Lasting Analgesia With Transdermal Fentanyl: A New Approach in Rat Neonatal Research. Frontiers in Pharmacology 13.
Crossref
Crossref
Albert Lin & Anuj Aggarwal. 2022. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics
55
61
.
Qier Zhou, Zhiwei Zhang, Songkai Long, Wanjun Li, Baiyun Wang & Na Liang. (2021) Opioids in cancer: The κ‑opioid receptor (Review). Molecular Medicine Reports 25:2.
Crossref
Crossref
Lynn Kohan, Sudheer Potru, Antje M Barreveld, Michael Sprintz, Olabisi Lane, Anuj Aryal, Trent Emerick, Anna Dopp, Sophia Chhay & Eugene Viscusi. (2021) Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Regional Anesthesia & Pain Medicine 46:10, pages 840-859.
Crossref
Crossref
Victoria D. Powell, Jack M. Rosenberg, Avani Yaganti, Claire Garpestad, Pooja Lagisetty, Carol Shannon & Maria J. Silveira. (2021) Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain. JAMA Network Open 4:9, pages e2124152.
Crossref
Crossref
Arnt F. A. Schellekens, Stijn E. Veldman, Eka S. D. Suranto, Steffie M. van Rijswijk, Selina E. I. van der Wal, Aart H. Schene & Marleen H. C. T. van Beek. (2021) Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder. Journal of Clinical Medicine 10:16, pages 3727.
Crossref
Crossref
Ke Ma, Wei Jiang, Yun-Xia Wang, Lin Wang, Yan Lv, Jin-Feng Liu, Rong-Guo Liu, Hui Liu, Li-Zu Xiao, Dong-Ping Du, Li-Juan Lu, Xiao-Qiu Yang, Ling-Jie Xia, Dong Huang, Zhi-Jian Fu, Bao-Gan Peng & Yan-Qing Liu. (2021) Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch. World Journal of Clinical Cases 9:9, pages 2110-2122.
Crossref
Crossref
Nisarg Patel, Eric S. Schwenk, Polina Ferd, Marc C. Torjman, Jaime L. Baratta & Eugene R. Viscusi. (2021) An anesthesiologist‐led inpatient buprenorphine initiative. Pain Practice.
Crossref
Crossref
Lysbeth H. Antonides, Annelies Cannaert, Caitlyn Norman, Niamh NicDáeid, Oliver B. Sutcliffe, Christophe P. Stove & Craig McKenzie. (2020)
Shape matters: The application of activity‐based
in vitro
bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug‐infused papers seized in prisons
. Drug Testing and Analysis 13:3, pages 628-643.
Crossref
Crossref
Andrew Davies, Charlotte Leach, Claire Butler, Amanda Gregory, Sarah Henshaw, Ollie Minton, Kate Shorthose & Kabir M. Batsari. (2021) Opioid-induced constipation in patients with cancer: a “real-world,” multicentre, observational study of diagnostic criteria and clinical features. Pain 162:1, pages 309-318.
Crossref
Crossref
Rebecca Ovsiowitz. 2021. Pain Care Essentials and Innovations. Pain Care Essentials and Innovations
163
174
.
Eric Prommer, Patricia Jacobs & Ambereen K. Mehta. 2021. Pain Care Essentials and Innovations. Pain Care Essentials and Innovations
91
111
.
Marthe M. Vandeputte, Annelies Cannaert & Christophe P. Stove. (2020) In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances. Archives of Toxicology 94:11, pages 3819-3830.
Crossref
Crossref
Alexander Gillis, Varun Sreenivasan & Macdonald J. Christie. (2020) Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window. Molecular Pharmacology 98:4, pages 410-424.
Crossref
Crossref
Ivan Urits, Cynthia Pham, Daniel Swanson, Kevin Berardino, Prudhvi Bandi, Ariunzaya Amgalan, Rachel J. Kaye, Jai Won Jung, Alan D. Kaye, Antonella Paladini, Giustino Varrassi, Adam M. Kaye, Laxmaiah Manchikanti & Omar Viswanath. (2020) The utilization of buprenorphine in chronic pain. Best Practice & Research Clinical Anaesthesiology 34:3, pages 355-368.
Crossref
Crossref
Joaquim Azevedo Neto, Anna Costanzini, Roberto De Giorgio, David G. Lambert, Chiara Ruzza & Girolamo Calò. (2020) Biased versus Partial Agonism in the Search for Safer Opioid Analgesics. Molecules 25:17, pages 3870.
Crossref
Crossref
Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, Julie Sanchez, Herman D. LimClaudia Alamein, Preeti Manandhar, Marina Santiago, Sebastian FritzwankerFrank SchmiedelTimothy A. Katte, Tristan Reekie, Natasha L. Grimsey, Michael Kassiou, Barrie Kellam, Cornelius Krasel, Michelle L. Halls, Mark Connor, J. Robert Lane, Stefan Schulz, Macdonald J. Christie & Meritxell Canals. (2020) Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science Signaling 13:625.
Crossref
Crossref
Marco Rossi, Giuseppe Casale, Danilo Badiali, Federica Aielli, Maria Antonietta Aloe Spiriti, Roberto Arcioni, Francesca Bordin, Maurizio Ferrara, Gloria Morelli Sbarra, Antonio Corcione, Franco Marinangeli & Paolo Marchetti. (2019) Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board. Supportive Care in Cancer 27:11, pages 4083-4090.
Crossref
Crossref
Sandip Roy Basunia, Baisakhi Laha & Avijit Hazra. (2022) Transdermal Buprenorphine versus Intramuscular Diclofenac for Postoperative Analgesia following Upper Abdominal Surgery under General Anesthesia: A Randomized Controlled Trial. Journal of Pharmacology and Pharmacotherapeutics 10:2, pages 57-62.
Crossref
Crossref
Beth WieseAdrianne R. Wilson-Poe. (2018) Emerging Evidence for Cannabis' Role in Opioid Use Disorder. Cannabis and Cannabinoid Research 3:1, pages 179-189.
Crossref
Crossref
Mellar P. Davis, Gavril Pasternak & Bertrand Behm. (2018) Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 78:12, pages 1211-1228.
Crossref
Crossref
Mohammad Zafar Imam, Andy Kuo, Sussan Ghassabian & Maree T. Smith. (2018) Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Neuropharmacology 131, pages 238-255.
Crossref
Crossref
R Douglas Bruce, Jessica Merlin, Paula J Lum, Ebtesam Ahmed, Carla Alexander, Amanda H Corbett, Kathleen Foley, Kate Leonard, Glenn Jordan Treisman & Peter Selwyn. (2017) 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV. Clinical Infectious Diseases 65:10, pages e1-e37.
Crossref
Crossref
Zunyong Liu, Yan Xu, Zhong-liang Liu, Yi-zhou Tian & Xiao-heng Shen. (2017) Combined application of diclofenac and celecoxib with an opioid yields superior efficacy in metastatic bone cancer pain: a randomized controlled trial. International Journal of Clinical Oncology 22:5, pages 980-985.
Crossref
Crossref
Sharon Rees. (2017) Buprenorphine—an atypical opioid: All you need to know. Nurse Prescribing 15:8, pages 402-408.
Crossref
Crossref
Stephan A. Schug & Sonya Ting. (2017) Fentanyl Formulations in the Management of Pain: An Update. Drugs 77:7, pages 747-763.
Crossref
Crossref
Matthias Thöns, Herbert Rusche & Bert Huenges. (2017) Strategien gegen den Schmerz. CME 14:3, pages 47-58.
Crossref
Crossref
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin, Asbjørn Mohr Drewes, Harald Breivik, Elon Eisenberg, Anton Emmanuel, Françoise Laroche, Winfried Meissner & Bart Morlion. (2016) Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Medicine, pages pnw255.
Crossref
Crossref
Flaminia Coluzzi, Robert TaylorJr.Jr., Joseph V. PergolizziJr.Jr., Consalvo Mattia & Robert B. Raffa. (2016) Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering). Brazilian Journal of Anesthesiology (English Edition) 66:3, pages 310-317.
Crossref
Crossref
Flaminia Coluzzi, Robert TaylorJr.Jr., Joseph V. PergolizziJr.Jr., Consalvo Mattia & Robert B. Raffa. (2016) Orientação para boa prática clínica para opioides no tratamento da dor: os três “Ts” – titulação (teste), ajustes (individualização), transição (redução gradual). Brazilian Journal of Anesthesiology 66:3, pages 310-317.
Crossref
Crossref
Eric Prommer. (2014) Buprenorphine for Cancer Pain. American Journal of Hospice and Palliative Medicine® 32:8, pages 881-889.
Crossref
Crossref
Eric E. Prommer. (2015) Pharmacological Management of Cancer-Related Pain. Cancer Control 22:4, pages 412-425.
Crossref
Crossref
B. Afsharimani, K. Kindl, P. Good & J. Hardy. (2015) Pharmacological options for the management of refractory cancer pain—what is the evidence?. Supportive Care in Cancer 23:5, pages 1473-1481.
Crossref
Crossref
R. Lauche, P. Klose, L. Radbruch, P. Welsch & W. Häuser. (2014) Opioide bei chronischen nicht-tumorbedingten Schmerzen – gibt es Unterschiede?Opioids in chronic noncancer pain—are opioids different?. Der Schmerz 29:1, pages 73-84.
Crossref
Crossref
Cho Naing, Peng Nam Yeoh & Kyan Aung. (2014) A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain. SpringerPlus 3:1.
Crossref
Crossref
D. Andrew Tompkins, Michael T. Smith, Miriam Z. Mintzer, Claudia M. Campbell & Eric C. Strain. (2014) A Double Blind, within Subject Comparison of Spontaneous Opioid Withdrawal from Buprenorphine versus Morphine. Journal of Pharmacology and Experimental Therapeutics 348:2, pages 217-226.
Crossref
Crossref
Karen J. Regina & Evan D. Kharasch. (2013) High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography–mass spectrometry. Journal of Chromatography B 939, pages 23-31.
Crossref
Crossref
Michael A. Überall. (2013) Chancen optimieren, Risiken minimieren. MMW - Fortschritte der Medizin 155:25, pages 63-71.
Crossref
Crossref
Matthew Pitlick & Deborah Fritz. (2013) Evidence About the Pharmacological Management of Constipation, Part 2. Home Healthcare Nurse 31:4, pages 207-216.
Crossref
Crossref
Tabitha Washington & Gilbert J. Fanciullo. 2013. Handbook of Methadone Prescribing and Buprenorphine Therapy. Handbook of Methadone Prescribing and Buprenorphine Therapy
201
211
.
Mellar P. Davis. (2012) Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain. The Journal of Supportive Oncology 10:6, pages 209-219.
Crossref
Crossref
. (2012) Wetenschappelijk bewijs. Pallium 14:5, pages 4-4.
Crossref
Crossref
Robert F WolffKim Reid, Marcello di Nisio, Dagfinn Aune, Carla Truyers, Adrian V Hernandez, Kate Misso, Rob Riemsma & Jos Kleijnen. (2012) Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain. Pain Management 2:4, pages 351-362.
Crossref
Crossref